Global Personalized Medicines Market Size, Status, Research and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 103

Report ID: 3486

Personalized medicine is tailoring of a treatment to a specific patient i.e. designing medicine treatment on the basis of diagnosis, disease condition, patient history, body physics, and other factors related to patients and diseases. Personalized medicine is also known as precision medicine, stratified medicine, or P4 medicine.
Growing healthcare expenditure levels triggering the need for an effective diagnostic procedure for cancer, growing prevalence of cancer and increasing usage of combination biomarkers for diagnostics are few factors expected to boost market growth.
In 2018, the global Personalized Medicines market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of 9.5% during 2019-2025.

This report focuses on the global Personalized Medicines status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Personalized Medicines development in United States, Europe and China.

The key players covered in this study
3G Biotech
Quest Diagnostics
Laboratory Corporation of America
Abbott
Agendia NV
Asuragen Inc
Becton Dickinson
CardioDx Inc.
Foundation Medicine
Qiagen
Siemens Healthcare
Amgen
Bristol-Myers Squibb
GE Healthcare
Pfizer
Sanofi
23andMe
Illumina

Market segment by Type, the product can be split into
PM Diagnostics
PM Therapeutics
Personalized Medical Care
Personalized Nutrition & Wellness

Market segment by Application, split into
Hospitals Pharmacies
Retail Pharmacies
Dietary Care Centers
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Personalized Medicines status, future forecast, growth opportunity, key market and key players.
To present the Personalized Medicines development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Personalized Medicines are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Personalized Medicines Market Size Growth Rate by Type (2014-2025)
1.4.2 PM Diagnostics
1.4.3 PM Therapeutics
1.4.4 Personalized Medical Care
1.4.5 Personalized Nutrition & Wellness
1.5 Market by Application
1.5.1 Global Personalized Medicines Market Share by Application (2014-2025)
1.5.2 Hospitals Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Dietary Care Centers
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Personalized Medicines Market Size
2.2 Personalized Medicines Growth Trends by Regions
2.2.1 Personalized Medicines Market Size by Regions (2014-2025)
2.2.2 Personalized Medicines Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Personalized Medicines Market Size by Manufacturers
3.1.1 Global Personalized Medicines Revenue by Manufacturers (2014-2019)
3.1.2 Global Personalized Medicines Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Personalized Medicines Market Concentration Ratio (CR5 and HHI)
3.2 Personalized Medicines Key Players Head office and Area Served
3.3 Key Players Personalized Medicines Product/Solution/Service
3.4 Date of Enter into Personalized Medicines Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Personalized Medicines Market Size by Type (2014-2019)
4.2 Global Personalized Medicines Market Size by Application (2014-2019)

5 United States
5.1 United States Personalized Medicines Market Size (2014-2019)
5.2 Personalized Medicines Key Players in United States
5.3 United States Personalized Medicines Market Size by Type
5.4 United States Personalized Medicines Market Size by Application

6 Europe
6.1 Europe Personalized Medicines Market Size (2014-2019)
6.2 Personalized Medicines Key Players in Europe
6.3 Europe Personalized Medicines Market Size by Type
6.4 Europe Personalized Medicines Market Size by Application

7 China
7.1 China Personalized Medicines Market Size (2014-2019)
7.2 Personalized Medicines Key Players in China
7.3 China Personalized Medicines Market Size by Type
7.4 China Personalized Medicines Market Size by Application

8 Japan
8.1 Japan Personalized Medicines Market Size (2014-2019)
8.2 Personalized Medicines Key Players in Japan
8.3 Japan Personalized Medicines Market Size by Type
8.4 Japan Personalized Medicines Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Personalized Medicines Market Size (2014-2019)
9.2 Personalized Medicines Key Players in Southeast Asia
9.3 Southeast Asia Personalized Medicines Market Size by Type
9.4 Southeast Asia Personalized Medicines Market Size by Application

10 India
10.1 India Personalized Medicines Market Size (2014-2019)
10.2 Personalized Medicines Key Players in India
10.3 India Personalized Medicines Market Size by Type
10.4 India Personalized Medicines Market Size by Application

11 Central & South America
11.1 Central & South America Personalized Medicines Market Size (2014-2019)
11.2 Personalized Medicines Key Players in Central & South America
11.3 Central & South America Personalized Medicines Market Size by Type
11.4 Central & South America Personalized Medicines Market Size by Application

12 International Players Profiles
12.1 3G Biotech
12.1.1 3G Biotech Company Details
12.1.2 Company Description and Business Overview
12.1.3 Personalized Medicines Introduction
12.1.4 3G Biotech Revenue in Personalized Medicines Business (2014-2019)
12.1.5 3G Biotech Recent Development
12.2 Quest Diagnostics
12.2.1 Quest Diagnostics Company Details
12.2.2 Company Description and Business Overview
12.2.3 Personalized Medicines Introduction
12.2.4 Quest Diagnostics Revenue in Personalized Medicines Business (2014-2019)
12.2.5 Quest Diagnostics Recent Development
12.3 Laboratory Corporation of America
12.3.1 Laboratory Corporation of America Company Details
12.3.2 Company Description and Business Overview
12.3.3 Personalized Medicines Introduction
12.3.4 Laboratory Corporation of America Revenue in Personalized Medicines Business (2014-2019)
12.3.5 Laboratory Corporation of America Recent Development
12.4 Abbott
12.4.1 Abbott Company Details
12.4.2 Company Description and Business Overview
12.4.3 Personalized Medicines Introduction
12.4.4 Abbott Revenue in Personalized Medicines Business (2014-2019)
12.4.5 Abbott Recent Development
12.5 Agendia NV
12.5.1 Agendia NV Company Details
12.5.2 Company Description and Business Overview
12.5.3 Personalized Medicines Introduction
12.5.4 Agendia NV Revenue in Personalized Medicines Business (2014-2019)
12.5.5 Agendia NV Recent Development
12.6 Asuragen Inc
12.6.1 Asuragen Inc Company Details
12.6.2 Company Description and Business Overview
12.6.3 Personalized Medicines Introduction
12.6.4 Asuragen Inc Revenue in Personalized Medicines Business (2014-2019)
12.6.5 Asuragen Inc Recent Development
12.7 Becton Dickinson
12.7.1 Becton Dickinson Company Details
12.7.2 Company Description and Business Overview
12.7.3 Personalized Medicines Introduction
12.7.4 Becton Dickinson Revenue in Personalized Medicines Business (2014-2019)
12.7.5 Becton Dickinson Recent Development
12.8 CardioDx Inc.
12.8.1 CardioDx Inc. Company Details
12.8.2 Company Description and Business Overview
12.8.3 Personalized Medicines Introduction
12.8.4 CardioDx Inc. Revenue in Personalized Medicines Business (2014-2019)
12.8.5 CardioDx Inc. Recent Development
12.9 Foundation Medicine
12.9.1 Foundation Medicine Company Details
12.9.2 Company Description and Business Overview
12.9.3 Personalized Medicines Introduction
12.9.4 Foundation Medicine Revenue in Personalized Medicines Business (2014-2019)
12.9.5 Foundation Medicine Recent Development
12.10 Qiagen
12.10.1 Qiagen Company Details
12.10.2 Company Description and Business Overview
12.10.3 Personalized Medicines Introduction
12.10.4 Qiagen Revenue in Personalized Medicines Business (2014-2019)
12.10.5 Qiagen Recent Development
12.11 Siemens Healthcare
12.12 Amgen
12.13 Bristol-Myers Squibb
12.14 GE Healthcare
12.15 Pfizer
12.16 Sanofi
12.17 23andMe
12.18 Illumina

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details